SVRA Icon

$SVRA

$SVRA

Savara

Savara is a clinical-stage biopharmaceutical company developing therapies for rare respiratory diseases, including a treatment for autoimmune pulmonary alveolar proteinosis.

Stocks

Total Asset Value

$136

Holders

1

Monthly Transfer Volume

$137.13

Savara Metrics

Tokenized Public Stocks

10 Total